GSK’s Arexvy vaccine shows promise for a broader age group in the RSV battle

admin 2023年12月22日

Beginner

science & technology, science & technology - beginner

©Leon Neal/Getty Images/FILE

Pre-reading questions:

I will read each question. Then, please answer them.

講師がそれぞれの質問を読むので答えましょう。

Do you know what a vaccine is?
Have you ever heard about the importance of vaccines for staying healthy?

Vocabulary:

I will read the words, meanings, and sample sentences. Then, repeat after me.

単語、意味、例文を読みます。講師に続いて音読しましょう。

disease /dih-ZEEZ/

[noun] – illness of people, animals, plants, etc., caused by infection or a failure of health rather than by an accident
The flu is a contagious disease that can make people feel very sick.

allow /uh-LOU/

[verb] – to give permission for someone to do something or to not prevent something from happening
The teacher will allow the students to use their textbooks during the exam.

conference /KON-fer-uhns/

[noun] – an event, sometimes lasting a few days, at which there is a group of talks on a particular subject, or a meeting in which especially business matters are discussed formally
I will be attending a medical conference next week to learn about the latest advancements in healthcare.

death /deth/

[noun] – the end of life
The death of a loved one can be a very difficult and emotional experience.

broader /BRAA-dr/

[adjective] – very wide
The company is planning to launch a broader marketing campaign to reach a larger audience.

Article reading:

Please read the whole article. Then, I will check your pronunciation and intonation.

記事を音読しましょう。講師はあなたの発音とイントネーションを確認します。

GlaxoSmithKline (GSK) is working to fight a contagious illness called respiratory syncytial virus (RSV), which can make people sick like the flu. This disease is especially risky for older adults. GSK has a vaccine called Arexvy, which was first allowed for people who are 60 years and older. Now, they have found that this vaccine may also help people who are 50 to 59 years old, especially if they have health problems like lung or heart issues or diabetes. GSK wants to tell the U.S. Food and Drug Administration (FDA) about these results so that more people can get the vaccine. Right now, only people who are 60 and older can get it.

GSK conducted a Phase 3 trial to test the vaccine on people aged 50–59 with health issues. Initial results are positive and awaiting expert review, and GSK aims to present the final results at a medical conference and in a reputable journal. Sharing with the FDA and regulators in 2024 is crucial because RSV can lead to hospitalizations and deaths, particularly in older individuals. The vaccine’s broader use could greatly improve public health.

True or False:

Read the sentences and identify if they are true or false based on the article.

文章を読んで、記事に基づいて正誤を答えましょう。

GSK is working to combat a contagious illness known as respiratory syncytial virus (RSV).
The vaccine Arexvy has only been allowed for people who are 60 years and older.
The initial results of the Phase 3 trial for the vaccine were negative.
The article mentions that RSV can lead to hospitalizations and deaths, especially in older individuals.
GSK is not planning to share the vaccine’s results with the U.S. Food and Drug Administration (FDA).

Fill in the blanks:

Choose the correct word from the table then fill in the blanks.

適切な言葉を選んで空欄を埋めましょう。

disease

allow

conference

death

broader

When attending a __________, it’s essential to bring your notes and be prepared to discuss the latest developments in your field.
The doctor explained that a healthy lifestyle can help prevent many types of chronic __________, such as heart disease and diabetes.
The new regulations will __________ companies to reduce their carbon emissions and promote eco-friendly practices.
By expanding access to education, we can create a __________ understanding of different cultures and promote tolerance and diversity.
In many cultures, the concept of __________ is accompanied by various rituals and traditions to honor and remember the deceased.